Birlasoft Q2 Margins, BFSI & Life Sciences Growth, Manufacturing Weakness | Angan Guha | ET Now　 #ETNOW

Birlasoft CEO & MD Angan Guha joins ET Now to break down the company’s Q2 performance led by BFSI and life sciences growth, even as manufacturing demand remained soft due to macro uncertainty. Guha discusses margin expansion to 16%, tail account rationalization, and future growth strategy under the new Americas CEO. He also shares insights on the $107 million TCV, deal pipeline, and FY26 growth outlook, emphasizing stronger revenue and order booking in H2.

#etnow #birlasoft #q2earnings #bfsi #manufacturing #topnews #q2results #businessnews #topnews #stockmarket

YouTube Channel – https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb

Social Media Links :-
Twitter – http://goo.gl/hA0vDt
Facebook – http://goo.gl/5Lr4mC

Website – https://ift.tt/po3ymB8